Related Experiment Video
Updated: Jul 14, 2026

Long Term Intravital Multiphoton Microscopy Imaging of Immune Cells in Healthy and Diseased Liver Using CXCR6.Gfp Reporter Mice
Published on: March 24, 2015
CXCL10/SLC11A1 Axis Exacerbates Septic Liver Injury by Regulating Neutrophil Extracellular Traps Formation to Drive
Haiping Lin1, Shicong Zheng1, Pei Song2
1Department of General Surgery, Jinhua Central Hospital, Teaching Hospital of Mathematical Medicine College, Zhejiang Normal University, Zhejiang, China.
Sepsis causes liver injury by activating neutrophils to release neutrophil extracellular traps (NETs) via the CXCL10-SLC11A1 axis. Targeting this pathway may treat sepsis-induced liver damage.
Area of Science:
- Immunology
- Hepatology
- Molecular Biology
Background:
- Intra-abdominal infection often leads to sepsis, a condition where the liver is frequently injured early.
- Neutrophil infiltration and activation are key features of sepsis-associated liver injury.
Purpose of the Study:
- To investigate the molecular mechanisms underlying sepsis-induced liver injury.
- To identify novel therapeutic targets for sepsis-associated liver damage.
Main Methods:
- Utilized a cecal ligation and puncture (CLP) mouse model with bulk and single-cell RNA sequencing.
- Performed conditional knockout of solute carrier family 11 member 1 (SLC11A1) in neutrophils.
- Analyzed hepatocyte secretion of C-X-C motif chemokine ligand 10 (CXCL10) and its effects on neutrophil extracellular traps (NETs) formation.
Main Results:
- Sepsis induced significant neutrophil infiltration in the liver, with upregulated SLC11A1 expression.
- Knockout of Slc11a1 in neutrophils attenuated liver injury and improved survival.
- A CXCL10-SLC11A1-NETs axis was identified, promoting pro-inflammatory macrophage polarization and exacerbating liver damage.
- Elevated CXCL10 levels in patients correlated with liver injury markers.
Conclusions:
- The study identified a novel CXCL10-SLC11A1-NETs signaling axis contributing to sepsis-induced liver injury.
- Targeting this axis, particularly CXCL10, presents a potential therapeutic strategy for sepsis-associated liver damage.
Related Concept Videos
Chronic Inflammation: Introduction
Cirrhosis II: Pathophysiology
Inflammatory Bowel Disease III: Crohn's Disease